Clinical factors for choosing active surveillance: an analysis of papillary thyroid microcarcinoma patients with recurrence

被引:0
|
作者
Won, Ho-Ryun [1 ,2 ]
Kim, Min Gyu [1 ]
Kim, Min Soo [1 ]
Chang, Jae Won [1 ,3 ]
Koo, Bon Seok [1 ,3 ]
机构
[1] Chungnam Natl Univ, Dept Otorhinolaryngol Head & Neck Surg, Coll Med, Daejeon, South Korea
[2] Chungnam Natl Univ, Dept Otorhinolaryngol Head & Neck Surg, Sejong Hosp, Sejong, South Korea
[3] Chungnam Natl Univ Hosp, Dept Otolaryngol Head & Neck Surg, Daejeon, South Korea
基金
新加坡国家研究基金会;
关键词
thyroid cancer; papillary thyroid microcarcinoma; active surveillance; recurrence; clinical factor; BRAF MUTATION; CANCER; ASSOCIATION; CARCINOMA;
D O I
10.1530/ETJ-23-0195
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective: Active surveillance (AS) has been suggested as a management option for low-risk papillary thyroid microcarcinoma (PTMC). However, the currently proposed selection criteria for AS application do not consider various clinical factors. The purpose of this study was to analyze clinical factors related to recurrence that could be confirmed preoperatively in patients who underwent surgery for PTMC and to identify factors worth considering when deciding whether to apply AS. Materials and methods: Data were collected from patients with PTMC who underwent surgical treatment at Chungnam National University Hospital. A retrospective cohort was established according to the presence or absence of recurrence during the follow-up period. In total, 2717 patients were enrolled, of whom 60 experienced recurrence. Various clinical factors that could be identified before surgery were analyzed. Results: The relationship between various clinical factors that could be confirmed preoperatively and recurrence was confirmed through Cox regression analysis and Kaplan-Meier curve analysis. BRAF mutation and the tall cell variant were significantly more common in patients with recurrence. In patients aged 55 years or older, the risk of recurrence was lower than in younger patients, while the recurrence-free survival (RFS) rate was higher. Conclusion: When choosing between surgical treatment or AS in PTMC patients, additional consideration of the patient's clinical factors, such as age and BRAF mutation status, may be required in addition to the existing criteria.
引用
收藏
页数:8
相关论文
共 50 条
  • [41] Low-risk papillary microcarcinoma of the thyroid: A review of active surveillance trials
    Ito, Y.
    Miyauchi, A.
    Oda, H.
    EJSO, 2018, 44 (03): : 307 - 315
  • [42] Clinicohistopathological factors influencing clinical outcome in papillary thyroid microcarcinoma
    Lee, Sun Seong
    Park, Ji Sun
    Choi, Su Jung
    Bae, Sang Kyun
    JOURNAL OF NUCLEAR MEDICINE, 2014, 55
  • [43] Active Surveillance of Papillary Thyroid Microcarcinoma: A Mini-Review from Korea
    Kim, Tae Yong
    Shong, Young Kee
    ENDOCRINOLOGY AND METABOLISM, 2017, 32 (04) : 399 - 406
  • [44] Improved outcomes for papillary thyroid microcarcinoma care: active surveillance and case volume
    Freni, Francesco
    Galletti, Bruno
    Galletti, Francesco
    Dionigi, Gianlorenzo
    THERAPEUTIC ADVANCES IN ENDOCRINOLOGY AND METABOLISM, 2018, 9 (07) : 185 - 186
  • [45] Thermal Ablation for the Management of Papillary Thyroid Microcarcinoma in the Era of Active Surveillance and Hemithyroidectomy
    Chung, Sae Rom
    Baek, Jung Hwan
    Choi, Young Jun
    Lee, Jeong Hyun
    CURRENT ONCOLOGY REPORTS, 2022, 24 (08) : 1045 - 1052
  • [46] Analysis of Risk Factors of Neck Nodal Metastasis in Patients with Papillary Thyroid Microcarcinoma
    Tirman, Baris
    Basoglu, Mahmut
    Karabulut, Kaan
    TURKISH JOURNAL OF ENDOCRINOLOGY AND METABOLISM, 2018, 22 (02) : 64 - 71
  • [47] Clinicopathological, immunohistochemical factors and recurrence associated with extrathyroidal extension in papillary thyroid microcarcinoma
    Kim, Woo Young
    Kim, Hoon Yub
    Son, Gil Soo
    Bae, Jeoung Won
    Lee, Jae Bok
    JOURNAL OF CANCER RESEARCH AND THERAPEUTICS, 2014, 10 (01) : 50 - 55
  • [48] Clinical and Pathologic Predictors of Lymph Node Metastasis and Recurrence in Papillary Thyroid Microcarcinoma
    Johnson, Daniel
    Cavallo, Allison
    Siddiqui, Saaduddin
    Angelos, Peter
    Grogan, Raymon
    Kaplan, Edwin
    DeMay, Richard
    Antic, Tatjana
    Cipriani, Nicole
    LABORATORY INVESTIGATION, 2015, 95 : 135A - 135A
  • [49] Clinical and Pathologic Predictors of Lymph Node Metastasis and Recurrence in Papillary Thyroid Microcarcinoma
    Johnson, Daniel
    Cavallo, Allison
    Siddiqui, Saaduddin
    Angelos, Peter
    Grogan, Raymon
    Kaplan, Edwin
    DeMay, Richard
    Antic, Tatjana
    Cipriani, Nicole
    MODERN PATHOLOGY, 2015, 28 : 135A - 135A
  • [50] Risk factors for skip metastasis in patients with papillary thyroid microcarcinoma
    Wu, Xin
    Li, Binglu
    Zheng, Chaoji
    He, Xiaodong
    CANCER MEDICINE, 2023, 12 (06): : 7560 - 7566